K. Hoekman et al., Hypoglycaemia associated with the production of insulin-like growth factorII and insulin-like growth factor binding protein 6 by a haemangiopericytoma, CLIN ENDOCR, 51(2), 1999, pp. 247-253
Non-islet-cell tumour-induced hypoglycaemia (NICTH) is, in most cases, attr
ibutable to tumour production of insulin-like growth factor II (IGF-II), Tu
mour-derived IGF-II has a higher than normal molecular weight (big 'IGF-II'
) and an impaired ability to form the normal ternary 150 kD complex with IG
F binding protein-3 (IGFBP-3) and the acid-labile subunit (ALS). Consequent
ly, tumoral IGF-II circulates mainly in smaller binary complexes which have
a higher bioavailability than the ternary complex.
We had the opportunity to analyze IGFs and IGF-related factors in both pre-
and post-operative blood, tumour tissue and tumour cyst fluid from a patie
nt with a disseminated haemangiopericytoma and severe hypoglycaemia. In add
ition, the effect of serum and tumour cyst fluid on autophosphorylation of
the insulin receptor was examined.
Patient serum contained low levels of IGF-I, IGFBP-3 and ALS, while the con
centrations of IGFBP-2 and IGFBP-6 were markedly elevated, The total level
of circulating IGF-II was within the normal range, but Biogel P-60 gel filt
ration of patient serum revealed that 77% of the IGF-II was present in high
molecular weight forms (normal: 10-15%), which decreased to 53% after part
ial removal of the tumour, Most of the IGF-II immunoreactivity in pre- and
post-operative patient serum was associated with 50-60 kD complexes with on
ly a minimal contribution (<10%) from the 150 kD complex, Tumour cyst fluid
contained excessive amounts of both big IGF-II and IGFBP-6.
Northern blot analysis of total mRNA isolated from the tumour demonstrated
high expression of the IGF-II gene and abundant 1.1 kb IGFBP-6 transcript,
while the genes encoding IGFBP-3, -4 and -5 were only weakly expressed and
mRNA of IGFBP-1, -2 and IGF-I could not be detected. mRNAs for the IGF type
II receptor could be easily demonstrated, whereas those for the insulin- a
nd IGF type I receptor were hardly detectable. In contrast to patient serum
tumour cyst fluid strongly stimulated the insulin receptor in vitro; The p
resent study suggests an important role of the simultaneous production of I
GF-II and IGFBP-6 in the pathophysiology of tumour-induced hypoglycaemia.